AG˹ٷ

STOCK TITAN

[6-K] Erayak Power Solution Group Inc. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

NCSM’s Q2-25 10-Q shows a clear YoY turnaround. Revenue rose 23% to $36.5 mm, driven by a 46% jump in product sales that offset an 19% decline in service revenue. Consolidated gross profit improved $2.5 mm and the operating loss narrowed to $2.0 mm from $4.2 mm. A $1.0 mm deferred-tax benefit plus FX gains lifted net income attributable to NCS to $0.9 mm ($0.34 diluted EPS) versus a $3.1 mm loss (-$1.21) last year.

For the six months, revenue climbed 18% to $86.5 mm and net income swung to $5.0 mm ($1.84 diluted EPS). Canada contributed 49% of Q2 sales, the U.S. 37%, and other markets 14%.

Balance sheet. Cash remained healthy at $25.4 mm; NCS drew no amounts on its $35 mm ABL facility. Total debt consists solely of $7.7 mm of finance leases. Equity increased to $124.0 mm.

Cash flow. H1 operating cash inflow fell to $1.9 mm from $4.1 mm on higher working-capital needs; capex was modest at $0.7 mm.

Strategic update. On 31-Jul-25 NCS closed the $5.9 mm cash acquisition of Reservoir Metrics to expand tracer diagnostics, with an earn-out of up to $1.3 mm.

Risks & Outlook. Management cites stable Canadian activity, softer U.S. completions, potential international growth, and cost headwinds from steel/chemical tariffs. Ongoing Canadian patent appeals and U.S. litigation could affect future results but no gain/loss has been booked.

Il rapporto 10-Q del Q2-25 di NCSM mostra un chiaro miglioramento anno su anno. I ricavi sono aumentati del 23% raggiungendo 36,5 milioni di dollari, trainati da un incremento del 46% nelle vendite di prodotti che ha compensato un calo del 19% nei ricavi dei servizi. Il profitto lordo consolidato è migliorato di 2,5 milioni di dollari e la perdita operativa si è ridotta a 2,0 milioni di dollari da 4,2 milioni. Un beneficio fiscale differito di 1,0 milione di dollari insieme a guadagni da cambi ha portato il reddito netto attribuibile a NCS a 0,9 milioni di dollari (EPS diluito di 0,34$) rispetto a una perdita di 3,1 milioni (-1,21$) dell'anno precedente.

Nei sei mesi, i ricavi sono saliti del 18% a 86,5 milioni di dollari e il reddito netto è passato a 5,0 milioni (EPS diluito di 1,84$). Il Canada ha contribuito per il 49% alle vendite del Q2, gli Stati Uniti per il 37% e altri mercati per il 14%.

Stato patrimoniale. La liquidità è rimasta solida a 25,4 milioni di dollari; NCS non ha utilizzato alcuna somma della linea di credito ABL da 35 milioni. Il debito totale è costituito esclusivamente da 7,7 milioni di dollari di leasing finanziari. Il patrimonio netto è salito a 124,0 milioni.

Flusso di cassa. Il flusso di cassa operativo del primo semestre è sceso a 1,9 milioni da 4,1 milioni a causa di maggiori esigenze di capitale circolante; gli investimenti in capitale sono stati modesti, pari a 0,7 milioni.

Aggiornamento strategico. Il 31 luglio 2025 NCS ha completato l’acquisizione in contanti da 5,9 milioni di Reservoir Metrics per espandere la diagnostica dei traccianti, con un earn-out fino a 1,3 milioni.

Rischi e prospettive. La direzione segnala un’attività stabile in Canada, un rallentamento nelle completions negli Stati Uniti, potenziale crescita internazionale e pressioni sui costi dovute a tariffe su acciaio e prodotti chimici. Appelli brevettuali in corso in Canada e contenziosi negli Stati Uniti potrebbero influenzare i risultati futuri, ma non sono state registrate perdite o guadagni al momento.

El informe 10-Q del segundo trimestre de 2025 de NCSM muestra una clara recuperación interanual. Los ingresos aumentaron un 23% hasta 36,5 millones de dólares, impulsados por un salto del 46% en las ventas de productos que compensó una caída del 19% en los ingresos por servicios. La ganancia bruta consolidada mejoró en 2,5 millones y la pérdida operativa se redujo a 2,0 millones desde 4,2 millones. Un beneficio fiscal diferido de 1,0 millón más ganancias por tipo de cambio elevaron el ingreso neto atribuible a NCS a 0,9 millones de dólares (EPS diluido de 0,34$) frente a una pérdida de 3,1 millones (-1,21$) del año anterior.

En los seis meses, los ingresos subieron un 18% a 86,5 millones y el ingreso neto pasó a 5,0 millones (EPS diluido de 1,84$). Canadá aportó el 49% de las ventas del segundo trimestre, EE.UU. el 37% y otros mercados el 14%.

Balance. El efectivo se mantuvo saludable en 25,4 millones; NCS no utilizó ninguna cantidad de su línea de crédito ABL de 35 millones. La deuda total consiste únicamente en 7,7 millones en arrendamientos financieros. El patrimonio aumentó a 124,0 millones.

Flujo de caja. El flujo de caja operativo del primer semestre cayó a 1,9 millones desde 4,1 millones debido a mayores necesidades de capital de trabajo; la inversión en capital fue modesta, 0,7 millones.

Actualización estratégica. El 31 de julio de 2025, NCS cerró la adquisición en efectivo de Reservoir Metrics por 5,9 millones para ampliar el diagnóstico de trazadores, con un earn-out de hasta 1,3 millones.

Riesgos y perspectivas. La dirección menciona una actividad estable en Canadá, una desaceleración en las completaciones en EE.UU., potencial crecimiento internacional y presiones en costos por aranceles al acero y productos químicos. Las apelaciones de patentes en Canadá y litigios en EE.UU. podrían afectar resultados futuros, pero no se han registrado ganancias o pérdidas hasta ahora.

NCSM� 2025� 2분기 10-Q 보고서는 명확� 전년 대� 반전� 보여줍니�. 매출은 23% 증가� 3,650� 달러�, 제품 판매가 46% 급증하여 서비� 매출 19% 감소� 상쇄했습니다. 연결 총이익은 250� 달러 개선되었�, 영업손실은 420� 달러에서 200� 달러� 축소되었습니�. 100� 달러� 이연세금 혜택� 환율 이익으로 NCS� 귀속되� 순이익은 90� 달러(희석 주당순이� 0.34달러)�, 전년도의 310� 달러 손실(-1.21달러)에서 크게 개선되었습니�.

상반� 매출은 18% 증가� 8,650� 달러, 순이익은 500� 달러(희석 주당순이� 1.84달러)� 전환되었습니�. 2분기 매출� 49%� 캐나�, 37%� 미국, 나머지 14%� 기타 시장에서 나왔습니�.

재무. 현금은 2,540� 달러� 건전� 수준� 유지했으�, NCS� 3,500� 달러 ABL 시설에서 차입하지 않았습니�. � 부채는 770� 달러� 금융리스� 포함됩니�. 자본은 1� 2,400� 달러� 증가했습니다.

현금 흐름. 상반� 영업 현금 유입은 운전자본 증가� 인해 410� 달러에서 190� 달러� 감소했으�, 자본� 지출은 70� 달러� 소폭이었습니�.

전략 업데이트. 2025� 7� 31�, NCS� 추적� 진단� 확대하기 위해 Reservoir Metrics� 590� 달러 현금으로 인수했으�, 최대 130� 달러� 추가 성과�(earn-out)� 포함되어 있습니다.

위험 � 전망. 경영진은 캐나다의 안정적인 활동, 미국 완성작업� 둔화, 잠재적인 국제 성장, 철강 � 화학 제품 관세로 인한 비용 압박� 언급했습니다. 현재 진행 중인 캐나� 특허 항소와 미국 소송� 향후 결과� 영향� 미칠 � 있으�, 아직 손익 반영은 없습니다.

Le rapport 10-Q du T2-25 de NCSM montre un clair retournement annuel. Le chiffre d'affaires a augmenté de 23 % pour atteindre 36,5 millions de dollars, porté par une hausse de 46 % des ventes de produits qui a compensé une baisse de 19 % des revenus de services. La marge brute consolidée s’est améliorée de 2,5 millions de dollars et la perte d’exploitation s’est réduite à 2,0 millions contre 4,2 millions. Un bénéfice fiscal différé de 1,0 million de dollars ainsi que des gains de change ont porté le bénéfice net attribuable à NCS à 0,9 million de dollars (BPA dilué de 0,34$) contre une perte de 3,1 millions (-1,21$) l’an passé.

Sur six mois, le chiffre d’affaires a progressé de 18 % à 86,5 millions et le bénéfice net est passé à 5,0 millions (BPA dilué de 1,84$). Le Canada a contribué à 49 % des ventes du T2, les États-Unis à 37 % et les autres marchés à 14 %.

Bilan. La trésorerie est restée saine à 25,4 millions; NCS n’a tiré aucun montant sur sa ligne de crédit ABL de 35 millions. La dette totale se compose uniquement de 7,7 millions de contrats de crédit-bail financier. Les capitaux propres ont augmenté à 124,0 millions.

Flux de trésorerie. Les flux de trésorerie opérationnels du premier semestre sont passés de 4,1 à 1,9 million en raison d’un besoin accru en fonds de roulement; les investissements en capital ont été modestes, à 0,7 million.

Mise à jour stratégique. Le 31 juillet 2025, NCS a finalisé l’acquisition au comptant de Reservoir Metrics pour 5,9 millions afin d’élargir le diagnostic des traceurs, avec un complément de prix (earn-out) pouvant aller jusqu’� 1,3 million.

Risques et perspectives. La direction évoque une activité stable au Canada, un ralentissement des opérations de complétion aux États-Unis, une croissance internationale potentielle et des pressions sur les coûts liées aux tarifs sur l’acier et les produits chimiques. Les appels en cours concernant des brevets au Canada et des litiges aux États-Unis pourraient affecter les résultats futurs, mais aucun gain ou perte n’a encore été enregistré.

Der 10-Q-Bericht von NCSM für das 2. Quartal 2025 zeigt eine deutliche Jahres-gegen-Jahres-Wende. Der Umsatz stieg um 23 % auf 36,5 Mio. USD, angetrieben durch einen 46%igen Anstieg der Produktverkäufe, der einen Rückgang der Serviceerlöse um 19 % ausglich. Der konsolidierte Bruttogewinn verbesserte sich um 2,5 Mio. USD und der operative Verlust verringerte sich von 4,2 Mio. USD auf 2,0 Mio. USD. Ein latenter Steuerbenefit von 1,0 Mio. USD sowie Wechselkursgewinne hoben den auf NCS entfallenden Nettogewinn auf 0,9 Mio. USD (verwässertes Ergebnis je Aktie von 0,34 USD) gegenüber einem Verlust von 3,1 Mio. USD (-1,21 USD) im Vorjahr.

Für die sechs Monate stiegen die Umsätze um 18 % auf 86,5 Mio. USD, und der Nettogewinn drehte auf 5,0 Mio. USD (verwässertes Ergebnis je Aktie von 1,84 USD). Kanada trug 49 % zum Umsatz im 2. Quartal bei, die USA 37 % und andere Märkte 14 %.

Bilanz. Die Liquidität blieb mit 25,4 Mio. USD gesund; NCS hat keine Beträge aus der 35-Millionen-USD-ABL-Kreditlinie in Anspruch genommen. Die Gesamtverschuldung besteht ausschließlich aus 7,7 Mio. USD Finanzierungsleasing. Das Eigenkapital stieg auf 124,0 Mio. USD.

Cashflow. Der operative Cashflow im ersten Halbjahr sank aufgrund höherer Working-Capital-Bedürfnisse von 4,1 Mio. USD auf 1,9 Mio. USD; die Investitionen waren mit 0,7 Mio. USD moderat.

Strategisches Update. Am 31. Juli 2025 schloss NCS die Barübernahme von Reservoir Metrics für 5,9 Mio. USD ab, um die Tracer-Diagnostik zu erweitern, mit einem Earn-out von bis zu 1,3 Mio. USD.

Risiken & Ausblick. Das Management nennt eine stabile Aktivität in Kanada, eine Abschwächung der US-Completion-Aktivitäten, potenzielles internationales Wachstum und Kostendruck durch Stahl- und Chemiezölle. Laufende Patentberufungen in Kanada und Rechtsstreitigkeiten in den USA könnten zukünftige Ergebnisse beeinflussen, jedoch wurden bisher keine Gewinne oder Verluste verbucht.

Positive
  • Revenue up 23% YoY in Q2-25, with product sales +46%.
  • Return to profitability: $0.9 mm net income vs. $3.1 mm loss prior year; diluted EPS $0.34.
  • Strong liquidity: $25.4 mm cash, no ABL borrowings, net leverage �0.
  • Equity grew to $124 mm; book value strengthened.
  • Accretive bolt-on acquisition of Reservoir Metrics for $5.9 mm expands tracer diagnostics.
Negative
  • Service revenue fell 19% YoY, signaling softer utilization.
  • Operating cash flow down to $1.9 mm from $4.1 mm due to working-capital build.
  • Ongoing litigation in Canada (Kobold) and U.S. appeals create financial uncertainty.
  • Tariff exposure on steel and Chinese chemicals could squeeze margins.
  • Seasonal and macro headwinds expected to reduce U.S. activity in H2-25.

Insights

TL;DR � Swing to profitability, solid liquidity, modest acquisition; overall positive.

Revenue growth was volume-led, with Canadian product sales the standout. The mix shift lifted gross profit despite service softness. Net income turned positive for both the quarter and YTD, aided by a $1.4 mm valuation-allowance release. Cash of $25 mm covers short-term needs and there is no ABL draw, leaving ample headroom. The small $5.9 mm Reservoir Metrics deal is easily financed and deepens the high-margin tracer line. Net leverage is effectively zero, giving flexibility should market conditions worsen. Guidance commentary suggests flat-to-down U.S. activity but stable Canada, implying H2 revenue may seasonally improve yet trail H1 levels. Overall, the filing signals improving fundamentals and prudent capital deployment.

TL;DR � Litigation and tariff exposure temper otherwise improving fundamentals.

While metrics improved, several contingencies persist. Canadian patent disputes with Kobold could ultimately impose damages or product constraints; timing remains uncertain. U.S. litigation wins against Nine and TCO are under appeal, so gains are non-cash for now. Tariff volatility—steel, aluminum and China-sourced chemicals—could pressure margins given limited pricing power in competitive markets. Operating cash flow weakened on higher inventories and receivables, a trend to monitor if activity slows. Nevertheless, zero revolver borrowings and modest capex reduce liquidity risk.

Il rapporto 10-Q del Q2-25 di NCSM mostra un chiaro miglioramento anno su anno. I ricavi sono aumentati del 23% raggiungendo 36,5 milioni di dollari, trainati da un incremento del 46% nelle vendite di prodotti che ha compensato un calo del 19% nei ricavi dei servizi. Il profitto lordo consolidato è migliorato di 2,5 milioni di dollari e la perdita operativa si è ridotta a 2,0 milioni di dollari da 4,2 milioni. Un beneficio fiscale differito di 1,0 milione di dollari insieme a guadagni da cambi ha portato il reddito netto attribuibile a NCS a 0,9 milioni di dollari (EPS diluito di 0,34$) rispetto a una perdita di 3,1 milioni (-1,21$) dell'anno precedente.

Nei sei mesi, i ricavi sono saliti del 18% a 86,5 milioni di dollari e il reddito netto è passato a 5,0 milioni (EPS diluito di 1,84$). Il Canada ha contribuito per il 49% alle vendite del Q2, gli Stati Uniti per il 37% e altri mercati per il 14%.

Stato patrimoniale. La liquidità è rimasta solida a 25,4 milioni di dollari; NCS non ha utilizzato alcuna somma della linea di credito ABL da 35 milioni. Il debito totale è costituito esclusivamente da 7,7 milioni di dollari di leasing finanziari. Il patrimonio netto è salito a 124,0 milioni.

Flusso di cassa. Il flusso di cassa operativo del primo semestre è sceso a 1,9 milioni da 4,1 milioni a causa di maggiori esigenze di capitale circolante; gli investimenti in capitale sono stati modesti, pari a 0,7 milioni.

Aggiornamento strategico. Il 31 luglio 2025 NCS ha completato l’acquisizione in contanti da 5,9 milioni di Reservoir Metrics per espandere la diagnostica dei traccianti, con un earn-out fino a 1,3 milioni.

Rischi e prospettive. La direzione segnala un’attività stabile in Canada, un rallentamento nelle completions negli Stati Uniti, potenziale crescita internazionale e pressioni sui costi dovute a tariffe su acciaio e prodotti chimici. Appelli brevettuali in corso in Canada e contenziosi negli Stati Uniti potrebbero influenzare i risultati futuri, ma non sono state registrate perdite o guadagni al momento.

El informe 10-Q del segundo trimestre de 2025 de NCSM muestra una clara recuperación interanual. Los ingresos aumentaron un 23% hasta 36,5 millones de dólares, impulsados por un salto del 46% en las ventas de productos que compensó una caída del 19% en los ingresos por servicios. La ganancia bruta consolidada mejoró en 2,5 millones y la pérdida operativa se redujo a 2,0 millones desde 4,2 millones. Un beneficio fiscal diferido de 1,0 millón más ganancias por tipo de cambio elevaron el ingreso neto atribuible a NCS a 0,9 millones de dólares (EPS diluido de 0,34$) frente a una pérdida de 3,1 millones (-1,21$) del año anterior.

En los seis meses, los ingresos subieron un 18% a 86,5 millones y el ingreso neto pasó a 5,0 millones (EPS diluido de 1,84$). Canadá aportó el 49% de las ventas del segundo trimestre, EE.UU. el 37% y otros mercados el 14%.

Balance. El efectivo se mantuvo saludable en 25,4 millones; NCS no utilizó ninguna cantidad de su línea de crédito ABL de 35 millones. La deuda total consiste únicamente en 7,7 millones en arrendamientos financieros. El patrimonio aumentó a 124,0 millones.

Flujo de caja. El flujo de caja operativo del primer semestre cayó a 1,9 millones desde 4,1 millones debido a mayores necesidades de capital de trabajo; la inversión en capital fue modesta, 0,7 millones.

Actualización estratégica. El 31 de julio de 2025, NCS cerró la adquisición en efectivo de Reservoir Metrics por 5,9 millones para ampliar el diagnóstico de trazadores, con un earn-out de hasta 1,3 millones.

Riesgos y perspectivas. La dirección menciona una actividad estable en Canadá, una desaceleración en las completaciones en EE.UU., potencial crecimiento internacional y presiones en costos por aranceles al acero y productos químicos. Las apelaciones de patentes en Canadá y litigios en EE.UU. podrían afectar resultados futuros, pero no se han registrado ganancias o pérdidas hasta ahora.

NCSM� 2025� 2분기 10-Q 보고서는 명확� 전년 대� 반전� 보여줍니�. 매출은 23% 증가� 3,650� 달러�, 제품 판매가 46% 급증하여 서비� 매출 19% 감소� 상쇄했습니다. 연결 총이익은 250� 달러 개선되었�, 영업손실은 420� 달러에서 200� 달러� 축소되었습니�. 100� 달러� 이연세금 혜택� 환율 이익으로 NCS� 귀속되� 순이익은 90� 달러(희석 주당순이� 0.34달러)�, 전년도의 310� 달러 손실(-1.21달러)에서 크게 개선되었습니�.

상반� 매출은 18% 증가� 8,650� 달러, 순이익은 500� 달러(희석 주당순이� 1.84달러)� 전환되었습니�. 2분기 매출� 49%� 캐나�, 37%� 미국, 나머지 14%� 기타 시장에서 나왔습니�.

재무. 현금은 2,540� 달러� 건전� 수준� 유지했으�, NCS� 3,500� 달러 ABL 시설에서 차입하지 않았습니�. � 부채는 770� 달러� 금융리스� 포함됩니�. 자본은 1� 2,400� 달러� 증가했습니다.

현금 흐름. 상반� 영업 현금 유입은 운전자본 증가� 인해 410� 달러에서 190� 달러� 감소했으�, 자본� 지출은 70� 달러� 소폭이었습니�.

전략 업데이트. 2025� 7� 31�, NCS� 추적� 진단� 확대하기 위해 Reservoir Metrics� 590� 달러 현금으로 인수했으�, 최대 130� 달러� 추가 성과�(earn-out)� 포함되어 있습니다.

위험 � 전망. 경영진은 캐나다의 안정적인 활동, 미국 완성작업� 둔화, 잠재적인 국제 성장, 철강 � 화학 제품 관세로 인한 비용 압박� 언급했습니다. 현재 진행 중인 캐나� 특허 항소와 미국 소송� 향후 결과� 영향� 미칠 � 있으�, 아직 손익 반영은 없습니다.

Le rapport 10-Q du T2-25 de NCSM montre un clair retournement annuel. Le chiffre d'affaires a augmenté de 23 % pour atteindre 36,5 millions de dollars, porté par une hausse de 46 % des ventes de produits qui a compensé une baisse de 19 % des revenus de services. La marge brute consolidée s’est améliorée de 2,5 millions de dollars et la perte d’exploitation s’est réduite à 2,0 millions contre 4,2 millions. Un bénéfice fiscal différé de 1,0 million de dollars ainsi que des gains de change ont porté le bénéfice net attribuable à NCS à 0,9 million de dollars (BPA dilué de 0,34$) contre une perte de 3,1 millions (-1,21$) l’an passé.

Sur six mois, le chiffre d’affaires a progressé de 18 % à 86,5 millions et le bénéfice net est passé à 5,0 millions (BPA dilué de 1,84$). Le Canada a contribué à 49 % des ventes du T2, les États-Unis à 37 % et les autres marchés à 14 %.

Bilan. La trésorerie est restée saine à 25,4 millions; NCS n’a tiré aucun montant sur sa ligne de crédit ABL de 35 millions. La dette totale se compose uniquement de 7,7 millions de contrats de crédit-bail financier. Les capitaux propres ont augmenté à 124,0 millions.

Flux de trésorerie. Les flux de trésorerie opérationnels du premier semestre sont passés de 4,1 à 1,9 million en raison d’un besoin accru en fonds de roulement; les investissements en capital ont été modestes, à 0,7 million.

Mise à jour stratégique. Le 31 juillet 2025, NCS a finalisé l’acquisition au comptant de Reservoir Metrics pour 5,9 millions afin d’élargir le diagnostic des traceurs, avec un complément de prix (earn-out) pouvant aller jusqu’� 1,3 million.

Risques et perspectives. La direction évoque une activité stable au Canada, un ralentissement des opérations de complétion aux États-Unis, une croissance internationale potentielle et des pressions sur les coûts liées aux tarifs sur l’acier et les produits chimiques. Les appels en cours concernant des brevets au Canada et des litiges aux États-Unis pourraient affecter les résultats futurs, mais aucun gain ou perte n’a encore été enregistré.

Der 10-Q-Bericht von NCSM für das 2. Quartal 2025 zeigt eine deutliche Jahres-gegen-Jahres-Wende. Der Umsatz stieg um 23 % auf 36,5 Mio. USD, angetrieben durch einen 46%igen Anstieg der Produktverkäufe, der einen Rückgang der Serviceerlöse um 19 % ausglich. Der konsolidierte Bruttogewinn verbesserte sich um 2,5 Mio. USD und der operative Verlust verringerte sich von 4,2 Mio. USD auf 2,0 Mio. USD. Ein latenter Steuerbenefit von 1,0 Mio. USD sowie Wechselkursgewinne hoben den auf NCS entfallenden Nettogewinn auf 0,9 Mio. USD (verwässertes Ergebnis je Aktie von 0,34 USD) gegenüber einem Verlust von 3,1 Mio. USD (-1,21 USD) im Vorjahr.

Für die sechs Monate stiegen die Umsätze um 18 % auf 86,5 Mio. USD, und der Nettogewinn drehte auf 5,0 Mio. USD (verwässertes Ergebnis je Aktie von 1,84 USD). Kanada trug 49 % zum Umsatz im 2. Quartal bei, die USA 37 % und andere Märkte 14 %.

Bilanz. Die Liquidität blieb mit 25,4 Mio. USD gesund; NCS hat keine Beträge aus der 35-Millionen-USD-ABL-Kreditlinie in Anspruch genommen. Die Gesamtverschuldung besteht ausschließlich aus 7,7 Mio. USD Finanzierungsleasing. Das Eigenkapital stieg auf 124,0 Mio. USD.

Cashflow. Der operative Cashflow im ersten Halbjahr sank aufgrund höherer Working-Capital-Bedürfnisse von 4,1 Mio. USD auf 1,9 Mio. USD; die Investitionen waren mit 0,7 Mio. USD moderat.

Strategisches Update. Am 31. Juli 2025 schloss NCS die Barübernahme von Reservoir Metrics für 5,9 Mio. USD ab, um die Tracer-Diagnostik zu erweitern, mit einem Earn-out von bis zu 1,3 Mio. USD.

Risiken & Ausblick. Das Management nennt eine stabile Aktivität in Kanada, eine Abschwächung der US-Completion-Aktivitäten, potenzielles internationales Wachstum und Kostendruck durch Stahl- und Chemiezölle. Laufende Patentberufungen in Kanada und Rechtsstreitigkeiten in den USA könnten zukünftige Ergebnisse beeinflussen, jedoch wurden bisher keine Gewinne oder Verluste verbucht.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2025

 

Commission File Number: 001-41568

 

Erayak Power Solution Group Inc.

 

No. 528, 4th Avenue

Binhai Industrial Park

Wenzhou, Zhejiang Province

People’s Republic of China 325025

+86-577-86829999

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒         Form 40-F ☐

 

 

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

On July 31, 2025, ERAYAK Power Solution Group Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors named thereto (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a registered direct offering (the “Registered Direct Offering”): (i) 32,155,921 class A ordinary shares (the “Class A Ordinary Shares”) of the Company of par value of $0.0001 each (the “Shares”), at a purchase price of $0.065 per share; and (ii) pre-funded warrants to purchase up to 75,536,386 Class A Ordinary Shares (the “Pre-Funded Warrants”) at a purchase price of $0.065 to the purchase price for Shares, less the exercise price of $0.0001 per share. .

 

The Registered Direct Offering closed on August 1, 2025. The Company received approximately $7 million in gross proceeds from the Registered Direct Offering, before deducting placement agent fees and estimated offering expenses. The Company intends to use the net proceeds from the Registered Direct Offering for its automated warehousing system, product development and certification, sales and marketing and working capital and inventory replenishment.

 

The Pre-Funded Warrants were sold to the Purchasers, whose purchase of the Shares in the Registered Direct Offering would otherwise have resulted in the Purchasers, together with its affiliates and certain related parties, beneficially owning more than 4.99% of the outstanding share capital of the Company following the consummation of the Registered Direct Offering. Each Pre-Funded Warrant represents the right to purchase one Class A Ordinary Share at an exercise price of $0.0001 per share. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until the Pre-Funded Warrants are exercised in full (subject to the beneficial ownership limitation described above).

 

The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions. Additionally, each of the directors and executive officers of the Company entered into a lock-up agreement, pursuant to which they agreed not to sell or transfer any of the Company securities which they hold, subject to certain customary exceptions, during the six (6) month period following the closing of the Registered Direct Offering.

 

The Shares, the Pre-Funded Warrants and Placement Agent Warrants, the Class A Ordinary Shares underlying the Pre-funded Warrants and the Placement Agent Warrants were offered by the Company pursuant to a registration statement on Form F-3 (File No.333-278347) (the “Registration Statement”), previously filed and declared effective by the Securities and Exchange Commission (the “Commission”) on May 16, 2024, the base prospectus filed as part of the Registration Statement, and the prospectus supplement dated August 1, 2025 (the “Prospectus Supplement”).

 

1

 

 

On July 31, 2025, the Company entered into a letter of engagement (the “LOE”) with Craft Capital Management LLC (“Craft” or the “Placement Agent”), pursuant to which the Company engaged Craft as the exclusive placement agent in connection with the Registered Direct Offering. The Placement Agent agreed to use its reasonable best efforts to arrange for the sale of the Shares and the Pre-Funded Warrants. In addition, under the Placement Agency Agreement the Company agreed to pay the Placement Agent a placement agent fee in cash equal to seven percent (6.0%) of the aggregate gross proceeds raised from the sale. The Company also agreed to reimburse the Placement Agent at closing for legal and other expenses incurred by them in connection with the Registered Direct Offering in an amount not to exceed $125,000. In connection with the Offering, the Company also issued, as additional compensation, warrants (the “Placement Agent Warrants”) to Craft Capital Management LLC (the “Placement Agent”) or its designees to purchase an aggregate of up to 6,461,538 Class A Ordinary Shares, being 6% of the aggregate number of the Shares and Pre-funded Warrant Shares (such shares that are issuable from time to time upon exercise of the Placement Agent Warrants (the “Placement Agent Warrant Shares”)). The Placement Agent Warrants are exercisable immediately after issuance and from time to time, in whole or in part, at an exercise price equal to $0.08125, being 125% of the purchase price of each Share, and will expire five (5) years following the closing of the offering.

 

The foregoing summaries of the Purchase Agreement, the Placement Agent Warrants, and the Pre-Funded Warrants do not purport to be complete and are subject to, and qualified in their entirety by, such documents filed as Exhibits 10.1 4.1 and 4.2, respectively, hereto and incorporated by reference herein. Copies of the press release related to the Registered Direct Offering entitled “Erayak Power Solution Group Inc. Announces $7 Million Registered Direct Offering” and “Erayak Power Solution Group Inc. Announces Closing of $7 Million Registered Direct Offering” are furnished as Exhibit 99.1 and 99.2 hereto and are incorporated by reference herein.

 

Copies of the opinions of Harney Westwood & Riegels and Ortoli Rosenstadt LLP relating to the legality of the issuance and sale of the Shares and the Pre-Funded Warrants, respectively, are filed as Exhibits 5.1 and 5.2 hereto, respectively.

 

This Report is incorporated by reference into the registration statements on Form F-3 (File No. 333-278347) of the Company, filed with the Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

This Report shall not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

Forward-Looking Statements:

 

This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, the Company is using forward-looking statements when it discusses the closing of the Registered Direct Offering. All statements other than statements of historical facts included in this Report are forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2024, filed with the Commission on April 23, 2025, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

2

 

 

Exhibit Index

 

Exhibit No.   Description
4.1   Form of Placement Agent Warrant
4.2   Form of Pre-Funded Warrant
5.1   Opinion of Harney Westwood & Riegels
5.2   Opinion of Ortoli Rosenstadt LLP
10.1   Securities Purchase Agreement, dated July 31, 2025, by and among the Company and the purchasers thereto
10.2   Letter of Engagement, dated July 31, 2025
23.1   Consent of Harney Westwood & Riegels (included in Exhibit 5.1)
23.2   Consent of Ortoli Rosenstadt LLP (included in Exhibit 5.2)
99.1   Press Release on Pricing of the Company’s Registered Direct Offering
99.2   Press Release on Closing of the Company’s Registered Direct Offering

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ERAYAK Power Solution Group Inc.
   
  By: /s/ Lingyi Kong
  Name:  Lingyi Kong
  Title: Chief Executive Officer

 

Date: August 1, 2025

 

4

FAQ

What were NCSM’s Q2 2025 revenues and how did they compare YoY?

$36.5 million, up 23% versus Q2 2024.

Did NCSM report a profit in Q2 2025?

Yes, net income attributable to NCS was $0.9 million or $0.34 diluted EPS, versus a $3.1 million loss last year.

How much cash and debt does NCSM have?

$25.4 million in cash and $7.7 million of finance-lease debt; no borrowings on the $35 million ABL facility.

What is the status of the Reservoir Metrics acquisition?

Closed on 31 July 2025 for $5.9 million cash plus up to $1.3 million earn-out, enhancing tracer diagnostics.

What legal matters could impact future results?

Patent appeals with Kobold in Canada and ongoing U.S. cases with Nine and TCO remain unresolved; no damages or gains are reflected yet.

Which geography contributed the largest share of Q2 2025 revenue?

Canada at 49%, followed by the United States at 37%.
Erayak Power Sol

NASDAQ:RAYA

RAYA Rankings

RAYA Latest News

RAYA Latest SEC Filings

RAYA Stock Data

5.76M
52.76M
29.63%
0.27%
Electrical Equipment & Parts
Industrials
China
Wenzhou